LS
Lam, Simon
8 yayın · 187 atıf · 2021–2025
Yayın
8
Atıf
187
Yıllar
4
Yayınlar
| Başlık | Yıl | Tip | Atıf |
|---|---|---|---|
|
Multi-omics characterization of improved cognitive functions in Parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial
|
2025 | Article | 2 |
|
Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases (Retraction of Vol 314, art no 121325, 2023)
|
2024 | Retraction | 0 |
|
Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases
|
2023 | Article | 6 |
|
Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial
|
2023 | Article | 60 |
|
Revealing the Molecular Mechanisms of Alzheimer's Disease Based on Network Analysis
|
2021 | Article | 19 |
|
Multi-omics approaches for revealing the complexity of cardiovascular disease
|
2021 | Review | 76 |
|
Systems Analysis Reveals Ageing-Related Perturbations in Retinoids and Sex Hormones in Alzheimer's and Parkinson's Diseases
|
2021 | Article | 17 |
|
Addressing the heterogeneity in liver diseases using biological networks
|
2021 | Review | 7 |